Back to Market Feed

Product Information

TLANDO 112.5 MG CAPSULE is a brand product labeled by Verity Pharmaceuticals Inc., priced at $7.1811 per EA under NDC 74676011202. Its NADAC has been published 59 times since Dec 11, 2024.

FDA first approved this application on Mar 28, 2022.

TLANDO 112.5 MG CAPSULE

testosterone undecanoate
$7.1811per EA
DEA Schedule CIII

Strength

112.5 mg/1

NDC

74676011202

Classification

Brand

Dosage Form

CAPSULE, LIQUID FILLED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TESTOSTERONE UNDECANOATE

Approval Type

New Drug (NDA)

FDA Application

NDA208088

FDA Approved

3/28/2022

On Market Since

4/15/2022

Pharmacological Classes

Androgen Receptor Agonists
Androgen
Androstanes

Price Statistics

The NADAC for TLANDO 112.5 MG CAPSULE has been published 59 times since Dec 11, 2024, and over the history we have for it it has risen 21.0%. The table below summarizes its recorded NADAC range and movement.

Current price$7.1811 per EA
All-time high$7.1811 (Aug 19, 2026)
All-time low$5.9332 (Dec 11, 2024)
52-week high$7.1811
52-week low$6.8232
Median price$6.8232
Average price$6.8374
Largest weekly change+15.0% (Jan 1, 2025)
Weeks tracked59
Tracking sinceDec 11, 2024

Price History

1W

+0.2%

1M

+0.2%

3M

+5.2%

6M

+5.2%

1Y

+5.2%

3Y

N/A

5Y

N/A

All

+21.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 5%

1 alternative • Same active ingredient

TLANDO 112.5 MG CAPSULE
Brand
54436011220•Antares Pharma, Inc.
$6.8232
Save 5%

Related Drugs

Same classification

TESTIM 1% (50 MG) GEL
Brand
66887000105•Endo USA Inc.
$3.7842
per GM
VOGELXO 50 MG/5 GRAM GEL
Brand
00245087105•Upsher-Smith Laboratories LLC
$3.7863
per GM
NATESTO NASAL 5.5 MG/0.122 GM
Brand
42667551101•Acerus Pharmaceuticals Corporation
$41.2770
per GM
XYOSTED 50 MG/0.5 ML AUTO-INJ
Brand
54436025004•Antares Pharma, Inc.
$316.0971
per ML
XYOSTED 75 MG/0.5 ML AUTO-INJ
Brand
54436027504•Antares Pharma, Inc.
$316.4489
per ML
XYOSTED 100 MG/0.5 ML AUTO-INJ
Brand
54436020004•Antares Pharma, Inc.
$316.6497
per ML

Frequently asked questions

What is the NADAC price of TLANDO 112.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TLANDO 112.5 MG CAPSULE, manufactured by Verity Pharmaceuticals Inc., is $7.1811 per EA (NDC 74676011202), effective Aug 19, 2026.

How has the price of TLANDO 112.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TLANDO 112.5 MG CAPSULE has risen 21.0%. It has been tracked across 59 weekly CMS publications since Dec 11, 2024.

What are the highest and lowest recorded NADAC prices for TLANDO 112.5 MG CAPSULE?

Since Dec 11, 2024, the NADAC for TLANDO 112.5 MG CAPSULE has ranged from a low of $5.9332 (Dec 11, 2024) to a high of $7.1811 (Aug 19, 2026), with a median of $6.8232 per EA.

Are there cheaper alternatives to TLANDO 112.5 MG CAPSULE?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TLANDO 112.5 MG CAPSULE, is $6.8232 per EA — about 5% below TLANDO 112.5 MG CAPSULE.

Who manufactures TLANDO 112.5 MG CAPSULE?

TLANDO 112.5 MG CAPSULE (NDC 74676011202) is labeled by Verity Pharmaceuticals Inc., and CMS classifies it as a brand product.